Maintenance fees coming due
197 maintenance fees come due in the 12 months from Nov 21, 2026, the next on Nov 21, 2026. Unpaid by May 21, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5
and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the
six month grace period that follows.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Fee due | Lapses if unpaid | Expires | Confidence |
|---|---|---|---|---|---|---|---|
| US 10,293,036 | Peptides and Combination of Peptides for Use in Immunotherapy Against NHL and Other Cancers In force Fee due Nov 21, 2026 Lapses if unpaid May 21, 2027 · High confidence | Immatics Biotechnologies GmbH | In force | Nov 21, 2026 | May 21, 2027 | High confidence | |
| US 11,655,280 | Immunotherapy with B*07 Restricted Peptides and Combination of Peptides Against Cancers and Related Methods In force Fee due Nov 23, 2026 Lapses if unpaid May 24, 2027 · High confidence | Immatics Biotechnologies GmbH | In force | Nov 23, 2026 | May 24, 2027 | High confidence | |
| US 11,655,281 | Immunotherapy with B*07 Restricted Peptides and Combination of Peptides Against Cancers and Related Methods In force Fee due Nov 23, 2026 Lapses if unpaid May 24, 2027 · High confidence | Immatics Biotechnologies GmbH | In force | Nov 23, 2026 | May 24, 2027 | High confidence | |
| US 11,667,685 | B*44 Restricted Peptides for Use in Immunotherapy Against Cancers and Related Methods In force Fee due Dec 6, 2026 Lapses if unpaid Jun 7, 2027 · High confidence | Immatics Biotechnologies GmbH | In force | Dec 6, 2026 | Jun 7, 2027 | High confidence | |
| US 10,314,896 | Novel Peptides and Combination of Peptides for Use in Immunotherapy Against Various Cancers In force Fee due Dec 11, 2026 Lapses if unpaid Jun 11, 2027 · High confidence | Immatics Biotechnologies GmbH | In force | Dec 11, 2026 | Jun 11, 2027 | High confidence | |
| US 10,314,897 | Novel Peptides and Combination of Peptides for Use in Immunotherapy Against Various Cancers In force Fee due Dec 11, 2026 Lapses if unpaid Jun 11, 2027 · High confidence | Immatics Biotechnologies GmbH | In force | Dec 11, 2026 | Jun 11, 2027 | High confidence | |
| US 10,314,898 | Novel Peptides and Combination of Peptides for Use in Immunotherapy Against NHL and Other Cancers In force Fee due Dec 11, 2026 Lapses if unpaid Jun 11, 2027 · High confidence | Immatics Biotechnologies GmbH | In force | Dec 11, 2026 | Jun 11, 2027 | High confidence | |
| US 10,314,899 | Novel peptides and combination of peptides and scaffolds for use in immunotherapy against Renal Cell Carcinoma (RCC) and other cancers In force Fee due Dec 11, 2026 Lapses if unpaid Jun 11, 2027 · High confidence | Immatics Biotechnologies GmbH | In force | Dec 11, 2026 | Jun 11, 2027 | High confidence | |
| US 10,316,062 | Immunotherapy Against Several Tumors, Such as Lung Cancer, Including Nsclc In force Fee due Dec 11, 2026 Lapses if unpaid Jun 11, 2027 · Medium confidence | Immatics Biotechnologies GmbH | In force | Dec 11, 2026 | Jun 11, 2027 | Medium confidence | |
| US 10,316,063 | Immunotherapy Against Several Tumors, Such as Lung Cancer, Including Nsclc In force Fee due Dec 11, 2026 Lapses if unpaid Jun 11, 2027 · Medium confidence | Immatics Biotechnologies GmbH | In force | Dec 11, 2026 | Jun 11, 2027 | Medium confidence | |
| 187 more maintenance fees coming due in the 12 months from Nov 21, 2026 · Pro | |||||||
10 of 197 patents shown. Soonest fee due date first, then patent number.
Pro members see every patent with a maintenance fee coming due: number, title, status, the due date, and the date it lapses if the fee goes unpaid through the grace period.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.